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Abstract
Purpose To develop a patient-reported outcome measure
for spasticity-related pain in children/adolescents (age
2–17 years) with cerebral palsy (CP), the ‘Questionnaire
on Pain caused by Spasticity (QPS).’
Methods Using a semi-structured interview guide, con-
cept elicitation interviews on spasticity-related pain in
upper and lower limbs were conducted in 21 children and
caregiver pairs. Data were used to modify initial QPS
modules and develop six draft modules, which were sub-
sequently refined and finalized in four consecutive cogni-
tive interview waves (12 children and caregiver pairs).
Results To accommodate the broad range in the chil-
dren’s communication skills, QPS child/adolescent mod-
ules were developed in both interviewer-administered and
self-administered formats. With the additional parent
modules, three QPS modules were developed for each of
the upper and lower limb applications. Information gained
from the parent/caregiver modules complements the child/
adolescent assessment. Parents report observed signs and
frequency of pain in the same situations used to capture the
child/adolescent reports of pain severity (e.g., rest, usual
daily activities, active mobilization, and physically difficult
activities). Participating children/adolescents and parents/
caregivers reported that the final QPS instruments were
comprehensive, relevant to the child’s spasticity-related
experience, and easy to understand and complete.
Conclusions The QPS is a novel instrument for the
assessment of spasticity-related pain in children/adoles-
cents with CP that was developed with direct patient input.
Its modules allow the use of this instrument in children/
adolescents with varied levels of impairment and commu-
nication skills.
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Abbreviations
CE Concept elicitation
CHEOPS Children’s Hospital of Eastern Ontario Pain
Scale
CP Cerebral palsy
FDA Food and Drug Administration
FLACC Faces, Legs, Activity, Cry, and Consolability
GMFCS Gross Motor Function Classification System
ObsRO Observer-reported outcome
PRO Patient-reported outcome
QoL Quality of life
QPS Questionnaire on Pain caused by Spasticity
SRP Spasticity-related pain
Introduction
Cerebral palsy (CP) is a motor impairment condition
caused by damage to the developing brain [1, 2]. Injury to
the motor areas may cause spasticity, in approximately
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80 % of patients, which is often accompanied by pain.
Further, CP-related disorders also include non-motor
symptoms such as impaired cognition, behavioral prob-
lems, and visual and hearing disorders, which can com-
promise communication ability. In pediatric patients with
spasticity, assessments and therapeutic interventions com-
monly focus on motor symptoms, but spasticity-related
pain (SRP) is often underreported and consequently un-
dertreated [3–7]. SRP can be continuous or recurrent; pain
incidence and severity may be affected by movements and
different activity situations throughout the day, for exam-
ple, at rest, when walking, when playing, or during phys-
ical therapy [4, 8–10].
Growing evidence suggests that in adults with spasticity,
SRP can be decreased by botulinum toxin injections [11, 12].
Even when intramuscular injections of botulinum toxin are
currently recommended for pediatric patients with CP [8, 13,
14], most clinical studies conducted in children/adolescents
have been small and outcome measures have not been con-
sistent or specifically developed for children with CP.
Assessing pain in children can be challenging, particu-
larly in children with cognitive impairments associated
with CP [6]. General measures of pain [15, 16] that are
commonly used in children focus on acute or chronic pain
[17], or rely on proxy or observational assessment of pain
[18]. There are some quality of life (QoL) assessments for
children with CP that include a limited number of pain
items [19–22]. Tools developed to specifically assess pain
in children with CP are tailored for severely disabled
children only, where pain behavior is evaluated by
healthcare professionals [23] or by the child through
scoring of daily situation drawings [24]. To date, there are
no instruments available that specifically assess SRP in
children with CP for use in clinical trials of botulinum
toxin and other therapies. Therefore, the therapeutic benefit
of botulinum toxin for SRP in children with CP needs to be
studied using well-developed outcome measures. Here, we
report the qualitative development and documentation of
content validity for the ‘Questionnaire on Pain caused by
Spasticity’ (QPS), a patient-reported outcome (PRO) and
observer-reported outcome (ObsRO) for the assessment of
SRP in children with CP.
Methods
Study design
The chronology of activities in the development of the QPS
is summarized in Fig. 1 and comprised four principal
phases: (1) literature review, (2) concept elicitation (CE)
interviews, (3) QPS revision, and (4) field testing with
cognitive interviews. The development of the QPS
conformed to the United States Food and Drug Adminis-
tration (FDA) and other good research practice guidelines,
which point out the importance of establishing proper
content validity for PRO’s and ObsRO’s in the target
patient population [25–27]. This study adhered to ethical
principles for human research studies and to good clinical
practice guidelines [28]. Appropriate institutional review
board approval was obtained before study activities began.
Caregivers received financial compensation for their time
and travel expenses associated with the study participation.
Literature review and preliminary draft measures
The decision to start with the QPS development was based
on a qualitative publications search in the PubMed data-
base (search terms: spasticity, pain, cerebral palsy, chil-
dren, and botulinum). The aim was to identify the current
peer-reviewed literature on SRP and available pain
assessments in children with CP and for botulinum toxin
treatment. General information about SRP was reviewed,
and findings on important concepts were outlined in four
initial draft questionnaire modules.
Concept elicitation interviews
CE interviews were conducted with the child/adolescent
and their parent/caregiver, following a semi-structured
Literature review & 
preliminary draft measures
Review of CE interview results, 
modification of initial draft measures 
and development of six revised 
modules of the QPS
CE interviews
Cognitive interviews to evaluate
revised modules of the QPS
Further refinement of revised modules
of the QPS
Finalization of the six modules
of the QPS
Fig. 1 Chronology of activities for developing the QPS. CE concept
elicitation, QPS Questionnaire on Pain caused by Spasticity
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interview guide. Initial open-ended questions explored the
presence of spasticity and SRP in patient language (e.g.,
‘What happens when your (leg/arm) gets tight or stiff?’
‘Does your (leg/arm) hurt sometimes?’ and ‘What happens
when it hurts?’). These questions were followed by probing
questions that explored the presence of the latter symptoms
in particular situations (e.g., ‘Do your arms ever tighten up
when you’re doing things like getting washed and dres-
sed?’). Interviewers also recorded visual clues, such as
children’s facial expressions and pointing, and explored
whether the Wong-Baker FACES scale [29] was under-
stood by the children and acceptable to the adolescents.
Interviews were audio-recorded, transcribed, and coded
using Atlas.ti software for content analysis. Inter-rater
agreement between coders was assessed on approximately
10 % of the transcript database. To assess saturation of
concepts, transcripts were ordered chronologically,
grouped into quartiles, and the newly appearing concept
codes for each new transcript group were compared to the
prior group. Saturation of concept was determined to have
been reached when there were no longer new concepts
being coded, and thus, all relevant concepts were captured.
Based on previous experience conducting qualitative
research and the degree of homogeneity in this population,
we estimated that saturation of concept would likely be
achieved within 14–16 CE interviews.
The study was conducted at four different clinical sites
in the USA with three trained and experienced interview-
ers. Cognitive interviews were subsequently conducted at
two of the four sites. Sites were selected in different geo-
graphic areas for their large pool of eligible subjects, to
avoid the clustering of regional effects. Sites were spe-
cialized for treatment of children with CP and were regu-
larly administering therapies such as botulinum toxin,
baclofen, or phenol to minimize spasticity. Patient records
were initially reviewed by clinical staff to identify suitable
families, and primary caregivers were approached if
eligible.
Purposive sampling was used to maximize variation in
both CE and cognitive interviews, so children in different
age brackets and with different gross motor function clas-
sification system (GMFCS) levels were recruited. Male and
female children (2–11 years) and adolescents (12–17 years)
with unilateral or bilateral CP with spasticity and intermit-
tent SRP in either the upper limb or the lower limb (or both)
on at least a weekly basis were eligible for participation.
Children were categorized into the following age bands for
recruitment: 2–4, 5–7, and 8–11-year old. To include the full
spectrum of children with CP, recruitment targeted children
with upper or lower limb SRP and with GMFCS of I–III
(ambulatory, less impaired) and IV–V (non-ambulatory,
greater impairment). Subjects had already received intra-
muscular botulinum toxin treatment of spasticity or were
likely candidates for this type of treatment. Subjects were
excluded if they had fixed contractures, predominant forms
of muscle hypertonia other than spasticity, constant pain,
pure, or predominantly dyskinetic CP, or had undergone
surgery for pes equinus in the 12 months prior to recruit-
ment. Subjects unable to answer interview questions due to
profound cognitive impairment were also excluded.
QPS revision
The CE interview results guided revisions of the initial
draft measures to develop the preliminary modules of the
QPS. Content validity assessment included the relevance of
concepts to subjects and caregivers, the specific language
used to describe symptoms and observed pain behaviors,
the appropriateness of the aspects of each concept being
measured (frequency, severity, duration of pain), and the
appropriateness of the recall period.
Cognitive interviews
In order to field test the QPS, four separate waves of
cognitive interviews were conducted (approximately four
interviews per wave) during which subjects and their
caregivers were asked to complete a preliminary module of
the QPS. Participants were asked to ‘think aloud’ and
describe their thought process for interpreting each ques-
tion and arriving at an answer. A sample of the questions
asked would be ‘Please tell me in your own words what
this item is asking you about’ (for caregivers) or ‘What did
you remember when you read this question?’ (for children).
The cognitive interview process was used to assess and
document the participant’s understanding of the underlying
concept presented in the QPS items and to refine language
and restructure difficult items for children and caregivers.
Other aspects of the preliminary QPS were also assessed,
including the appropriateness of the recall period, the fit of
the response options, the suitability of the Wong-Baker
FACES scale [29], and overall clarity of the format and
instructions.
An additional 12 child and parent/caregiver pairs were
enrolled in four separate waves of the cognitive interviews
to assess the preliminary measure.
Results
Literature review and preliminary draft measures
The main findings of the literature review can be summa-
rized as followed: (1) Pain in children with CP is an under-
recognized and emerging topic in this population due to the
significant influences on QoL [3, 7–9]; (2) SRP is one of
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multiple pain sources and needs to be distinguished from
others such as hip dislocation, dystonia, surgeries, or con-
tractures [6, 10]; (3) several general, acute pain assess-
ments, and QoL questionnaires with pain items are
available, but none specific for SRP in children and ado-
lescents with CP and following actual guidelines [15, 16,
25–27]; (4) pain severity, frequency, and location in
dependence on different activity situations are important
[8, 10, 16]; and (5) a modular approach for an assessment is
necessary to differentiate between upper and lower limb
SRP and to account for different ages or cognitive abilities
of the patients [1, 8]. This supports the development of a
parent/caregiver module to capture observed signs of SRP
in children who were either too young or too impaired to
communicate. Based on the review, four initial draft
modules were created: one upper and lower extremity
child/adolescent module and one upper and lower
extremity parent/caregiver module. These modules corre-
sponded to each other in structure and item content across a
general pain item and three different activity situations (at
rest, usual activities, and active mobilization) plus an item
on location of pain. A 7-day recall period was selected
based on considerations that (1) SRP is characterized as
intermittent and not constant pain, so sufficient time was
needed for the subject to have experienced pain to report
about; (2) specific activities such as physical exercises and
clinical therapy sessions relate more to a weekly schedule
than a daily one; and (3) qualitative evidence with both
children and parents indicated reliable memory for the past
week (7 days) for activity and pain reporting, but not
beyond that.
Concept elicitation interviews
CE interviews were conducted with 21 children (aged
2–16 years) and caregiver pairs (Table 1). Subjects’ cog-
nitive skills varied widely within age groups and GMFCS
levels. Findings confirmed that SRP and spasticity itself
were relevant to children and caregivers and affected their
everyday lives. In total, 40 relevant symptom concepts
were identified in the CE interviews. Larger domains such
as ‘pain related to spasticity’ included sub-concepts such as
‘pain at rest,’ ‘pain triggered by specific activities,’ ‘pain
severity,’ or ‘pain frequency’.
Table 1 Child and caregiver
population and demographics
GMFCS Gross Motor Function
Classification System, SD
standard deviation
a Twelve pairs (10 children and
11 caregivers) were enrolled for
the cognitive interviews. Two
caregivers had children who
were too young to be
interviewed, and one caregiver
was the mother of a pair of
participating twins (and was
interviewed twice)
Concept elicitation interviews Cognitive interviews
Children/adolescents (n = 21) (n = 10a)
Age (years)
Mean (SD) 9.5 (3.8) 12.1 (2.8)
Range 2–16 7–16
Female, n (%) 6 (28.6) 5 (50.0)
Ethnicity, n (%)
White (non-Hispanic) 16 (76.2) 5 (50.0)
White (Hispanic) 4 (19.0) 3 (30.0)
Hispanic/Latino 0 2 (20.0)
Black/African American 1 (4.8) 0
Cognitive impairment for age (reported by
caregivers), n (%)
7 (33.3) 3 (30.0)
GMFCS evaluation
GMFCS Level I–III 12 (57 %) 5 (50 %)
GMFCS Level IV–V 9 (43 %) 5 (50 %)
Localization of pain, n (%)
Both lower limbs only 2 (9.5) 3 (30.0)
One lower limb only 1 (4.8) 0
One upper and one lower limb, same side 6 (28.6) 0
Upper and lower limb(s) on both sides 12 (57.1) 7 (70.0)
Caregivers (n = 21) (n = 11a)
Age (years)
Mean (SD) 36.1 (7.7) 42.0 (7.3)
Range 22–58 32–53
Female, n (%) 20 (95.2) 10 (90.9)
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Saturation of concept was achieved by the fourth tran-
script group. Inter-rater agreement was between 92.3 and
94.9 % for the assignment of specific concept codes.
The most frequently mentioned symptom-related con-
cept was ‘Pain experienced in general,’ with 50 expressions
(10.9 % of all symptom expressions) in the child inter-
views and 36 expressions (7.8 % of all symptom expres-
sions) in the caregiver interviews. This code category
mainly captured children saying ‘it hurts,’ and caregivers
reporting ‘pain’ and ‘hurt.’ The pain experienced by the
children differed depending on the type of activity they
engaged in. The next most frequently expressed symptom
concept was ‘tightness’ (used to describe spasticity), with
27 expressions in child interviews (5.9 %) and 62 in
caregiver interviews (13.5 %).
Generally, the children were not able to describe fre-
quency or duration of their SRP in a reliable way, but they
could identify pain intensity/severity using the Wong-
Baker FACES scale [29].
All caregivers reported having observed SRP behaviors
in their children during the last 7 days; yet, only 16
(76.2 %) of the children acknowledged having pain. One
child directly stated he would deny pain: ‘Sometimes it
hurts so bad, but I’ll never tell you.’ Caregivers most fre-
quently detected pain by ‘observing body movement’
(n = 113, 17.4 % of the caregivers’ expressions for pain
detection) followed by other signs such as ‘the child
articulating pain,’ ‘changing the position of their body,’
‘having mood changes,’ and ‘having different facial
expressions’ [n = 102 (15.7 %); n = 68 (10.5 %); n = 45
(6.9 %); and n = 39 (6.0 %), respectively]. Most care-
givers were able to report on the frequency of pain based
on their observations of pain behaviors and their child’s
verbalization of pain.
QPS revision
CE interviews confirmed that certain children were able to
communicate about their pain, but did not have the cog-
nitive or motor abilities to answer a questionnaire on their
own. Accordingly, interviewer-administered modules were
needed to be developed to cover a higher percentage of the
target population. A total of six QPS modules were next
drafted (Table 2): two child/adolescent self-administered
modules, two child/adolescent interviewer-administered
modules, and two parent/caregiver modules.
Content analysis of the CE interview results determined
the selection of 11 symptom concepts (assessed in 11 of 12
items) for the child/adolescent modules and 12 symptom
concepts (assessed in 12 of 17 items) for the parent/care-
giver modules of the QPS (Table 3). It was also confirmed
that a 7-day recall period was appropriate for this age
group.
Items in the four child/adolescent modules probe the
occurrence of SRP (‘Yes/No’) and pain intensity (Wong-
Baker FACES scale) in different activity situations (pain
in general, at rest, during usual activities, during physical
therapy, and while performing a self-defined very difficult
task) during the last 7 days. The caregiver modules probe
for behaviors caregivers recognize as indicating pain and
how frequently these behaviors were observed in the dif-
ferent activity situations on a five-point response scale
from 0 = never to 4 = always. An example item of the
upper extremity child/adolescent module and the corre-
sponding items in the parent/caregiver module are pre-
sented in Fig. 2. Pain location was evaluated by caregivers
and children together and included only in the caregiver’s
questionnaire.
Cognitive interviews
Cognitive interviews were conducted with 12 child (aged
7–16 years) and caregiver pairs. The demographic and
clinical characteristics of subjects and caregivers are
detailed in Table 1.
Cognitive interviews with children and adolescents
The formatting and wording of the questionnaire were
amended in response to difficulties identified during the
interview waves. For instance, the phrase ‘think about the
last week’ made younger children think about the pain
events in the week prior to the interview, rather than the
week of the interview. Therefore, the wording was first
amended to ‘in the last week’ and then to ‘think about
today and the last 6 days’ when it became apparent that
adolescents were not considering ‘today’ when asked about
pain events ‘in the last week.’ In the fourth wave of cog-
nitive interviews, all subjects interviewed considered the
Table 2 The final six modules of the QPS
Upper extremity assessment Lower extremity assessment
Parent/caregiver observational report module Parent/caregiver observational report module
Child/adolescent self-administered module Child/adolescent self-administered module
Child/adolescent interviewer-administered module Child/adolescent interviewer-administered module
Qual Life Res (2014) 23:887–896 891
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full range of the last 7 days for their answers, indicating
that the wording of the recall period was adequate. Some
children with CP denied their pain, similar to observations
in the CE interviews.
Cognitive interviews with parents and caregivers
Most changes to the wording of the QPS were made after
the first interview wave. Examples include the addition of
‘tightness’ as a descriptor next to ‘spasticity’ throughout
the QPS, making a clearer distinction between nonverbal
signs of pain and verbal expressions. Some caregivers
selected their answers thinking of the last time they had
observed signs of pain in a given activity situation, which
in some cases went beyond the desired 7-day recall period.
Therefore, clinic staff administering the QPS will be
trained to verbally remind of the recall period. Table 4
illustrates changes made to the parent/caregiver QPS dur-
ing the cognitive interview waves for an example item
(SRP at rest). At the completion of the fourth wave of
cognitive interviews, no further wording or format changes
were needed for either the child/adolescent or parent/
caregiver modules of the QPS.
During the cognitive interviews, children and caregivers
judged the QPS to be easy to understand, complete, and
relevant to their experience with SRP. A reference manual
Table 3 Concepts in spasticity-related pain selected for inclusion in the QPS













Spasticity 1 Yes/no Spasticity (observed) 5 Yes/no
General spasticity-related pain (SRP) 2 Yes/no General SRP (verbalization) 6 Yes/no
General SRP severity 3 WBFa General SRP (observed signs) 7 Yes/no
SRP while at rest 4 Yes/no General SRP observed frequency 8 Frequencyb
SRP while at rest severity 5 WBFa SRP while at rest (observed signs) 9 Yes/no
SRP during usual activities 6 Yes/no SRP while at rest observed frequency 9b Frequencyb
SRP during usual activities severity 7 WBFa SRP during usual activities (observed signs) 10 Yes/no
SRP during active mobilization 8 Yes/no SRP during usual activities observed frequency 10b Frequencyb
SRP during active mobilization severity 9 WBFa SRP during active mobilization (observed signs) 11 Yes/no
SRP during difficult activity 11 Yes/no SRP during active mobilization observed frequency 11b Frequencyb
SRP during difficult activity severity 12 WBFa SRP during difficult activity (observed signs) 13 Yes/no
SRP during difficult activity observed frequency 13b Frequencyb
Items not described in this table collect additional information of interest such as role of the caregiver, definitions, pain location, etc.
QPS Questionnaire on Pain caused by Spasticity, SRP spasticity-related pain
a WBF: Wong-Baker FACES scale, includes six faces ranging from smiling to crying with scores of no hurt (0), hurts little bit (2), hurts little
more (4), hurts even more (6), hurts whole lot (8), and hurts worst (10)


















Think about today and the last 6 days. When you were doing things like
getting dressed, eating, or playing, did your shoulder, arm or hand hurt
when it got tight?
Circle your answer.
6.




During the last 7 days. When your child was doing his/her usual activities
(getting dressed, eating, or playing), did you see any signs of pain at the
time his/her shoulder, arm or hand got tight?
Circle your answer.
10.
My child is not able to move around by him/herself at all (not even in wheelchair)
YES NO
How often did you see these signs of pain in your child while he/she was















Fig. 2 Item examples of the final QPS. a Item 6 and 7 of the upper
extremity child/adolescent module. b Item 10 of the upper extremity
parent/caregiver module
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was developed to help guide clinical staff in selecting the
appropriate module of the child/adolescent QPS (self-
administered vs. interviewer-administered), based on the
subjects’ motor and cognitive skills, and to help with any
problems that might occur.
Discussion
The QPS was developed as a novel PRO and ObsRO
instrument for assessing SRP in children and adolescents
with CP from 2 to 17 years. Qualitative results from the CE
interviews and from the cognitive interviews supported
concept relevance for both children and their parents.
The most common pain assessment instruments used in
very young children are proxy reported, such as the Chil-
dren’s Hospital of Eastern Ontario Pain Scale (CHEOPS)
[30] or the Faces, Legs, Activity, Cry, and Consolability
(FLACC) Pain Assessment Tool [31]. The widely used
OUCHER!TM scale has been developed to assist 3- to
12-year olds to describe pain intensity [32]. All of these
tools evaluate acute pain, for example, after surgery. The
QPS is specifically designed to assess chronic SRP in
children with CP aged 2 years and older.
The review of the available literature highlighted that
SRP can be continuous or recurrent and varies in the type
of trigger, intensity, frequency, or duration according to
different activity situations [8]. CE interviews ensured that
the QPS allows for complete evaluation of SRP by
assessing pain triggered by different key activity situations.
In our study, most children could only reliably report pain
severity, but not pain frequency or duration. Therefore, the
child/adolescent modules of the QPS only ask about pain
intensity. The parent/caregiver can only report observed
signs of pain and the frequency of those signs; conse-
quently, the parent/caregiver modules of QPS only report
on observed signs of pain and their frequency, but not on
the subjective experience of pain intensity. Since the
qualitative results showed that pain duration was not reli-
ably reported by either the children or their parents/care-
givers, it is not addressed in any module of the QPS.
Qualitative results from both CE and cognitive inter-
views helped to ensure that the QPS used language
appropriate for assessing pain in younger children. Most
children and many of the parents/caregivers could not
relate to the term ‘spasticity.’ The children reported
experiencing ‘tightness,’ and therefore, this was the term
used in the QPS modules for both children and parents. The
Wong-Baker FACES scale has previously been shown to
be easy to use and preferred by children, parents, and
healthcare professionals when compared with other faces
pain scales [33]. We found the scale to be both appropriate
and helpful for this population of children with CP, and it
was therefore incorporated into the QPS.
Table 4 Example of the refinement of the QPS in cognitive interviews
Items evaluated in Wave 1 Items evaluated in Wave 2 Items evaluated in Wave 3 Items evaluated in Wave 4
Instructions: Now, we will ask
you about your child’s pain
caused by spasticity in some
specific situations
Instructions: Now, we will ask
you about your child’s pain
caused by spasticity (tightness)
in some specific situations
Instructions: Now, we will ask
you about your child’s pain
caused by spasticity (tightness)
in some specific situations
Instructions: Now, we will ask
you about your child’s pain
caused by spasticity (tightness)
in some specific situations
Item 9—lower
During the last 7 days, when your
child was at rest (sitting,
relaxing, watching TV,
sleeping), did you see signs of
pain at the time his/her hip, leg,
or foot got tight?
Circle your answer
Item 9—lower
During the last 7 days, when your
child was at rest (sitting,
relaxing, watching TV,
sleeping), did you see signs of
pain at the time his/her hip, leg,
or foot got tight?
Circle your answer
Item 9—lower
During the last 7 days, when your
child was at rest (sitting,
relaxing, watching TV,
sleeping), did you see any signs
of pain at the time his/her hip,
leg, or foot got tight?
Circle one answer
Item 9—lower
During the last 7 days, when your
child was at rest (relaxing,
watching TV, sleeping), did
you see any signs of pain at the




During the last 7 days, when your
child was at rest (sitting,
relaxing, watching TV,
sleeping), did you see signs of
pain at the time his/her
shoulder, arm, or hand got tight?
Circle your answer
Item 9—upper
During the last 7 days, when your
child was at rest (sitting,
relaxing, watching TV,
sleeping), did you see signs of
pain at the time his/her shoulder,
arm, or hand got tight?
Circle your answer
Item 9—upper
During the last 7 days, when your
child was at rest (sitting,
relaxing, watching TV,
sleeping), did you see any signs
of pain at the time his/her
shoulder, arm, or hand got tight?
Circle one answer
Item 9—upper
During the last 7 days, when your
child was at rest (relaxing,
watching TV, sleeping), did
you see any signs of pain at the
time his/her shoulder, arm, or
hand got tight?
Circle one answer
Yes/no Yes/no Yes/no Yes/no
This table illustrates typical changes that were made to the draft measures over the four waves of cognitive interviews, using an example item
from the caregiver module of the QPS. Changes are italicized
QPS Questionnaire on Pain caused by Spasticity
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A suitable recall period should provide a more inte-
grated assessment than a description of pain at a particular
moment [34]. However, a recall period that is too long may
be difficult to remember accurately, especially for younger
or intellectually impaired children [35]. Previous studies
have reported the successful use of a 1-week recall period
with children [36, 37]. During the cognitive interviews,
parents and children could clearly relate events to the 7-day
timeframe, confirming that this recall period was appro-
priate for the QPS.
The six-specific modules of the QPS are a novel feature
of this instrument. This unique design allows information
on symptom severity to be obtained from very young or
cognitively impaired children through the use of an inter-
viewer-administered module, without the loss of important
data due to age, insufficient reading skills, or communi-
cation impairment. Some children with CP will be capable
of self-administering the QPS, while others lacking suffi-
cient motor or reading skills will be able to complete the
interviewer-administered module. Additionally, the parent/
caregiver module of the QPS allows parents or caregivers
to provide valuable information on behalf of children who
are too young or unable to communicate due to cognitive
impairments. Each of the three modules has versions for
upper and lower extremities for the separate assessment of
spasticity in these parts of the body.
Interestingly, some of the children interviewed were
reluctant to admit having pain; some would not even admit
having spasticity. This qualitative study confirmed that this
was a conscious denial of SRP and not due to the child’s
inability to recognize pain or to understand the concept of
spasticity as ‘tightness.’ However, as shown in the cogni-
tive interview process, the unique design and flow of the
QPS was able to depict children’s initial denial of pain with
an early general question and then subsequently capture the
admission of pain in the more detailed questions regarding
different activity situations that trigger pain.
One critical point of a qualitative study is appropriate
sample size. Sample size is hard to define for a PRO, but
should be guided by the heterogeneity of the population
and the complexity of concepts. Saturation of concept is
then the key criterion to determine appropriateness of the
chosen sample size [26], which was successfully demon-
strated in this study. The predominant factor influencing
the heterogeneity in the population is the varying clinical
presentation of CP with respect to motor skills (upper and
lower limb, unilateral vs. bilateral), cognition (about 50 %
of children show relevant impairment), learning, as well as
hearing and seeing [1]. Using a pragmatic approach, we
concluded that CP subjects with marked limitation of
cognition and communication would not be able to con-
tribute to the initial phases of the development of a mea-
sure for SRP. We therefore aimed to have as much input
from CP children and adolescents who were able to com-
municate. Due to the implementation of broad input from
pediatric subjects, we succeeded in building a measure that
is clear and has simple concepts. Vocabulary was aimed to
fit the younger children and yet still be acceptable to the
older ones. Since a 12-year-old child with CP may have the
communication skills of a 5-year old, the best approach
was to tailor the measures to the lowest reading level and to
suggest a decision-making process for selecting which
version was most appropriate for a given child. Hence,
practical decision criteria such as motor skills, cognition,
and the ability to read and write are important for a PRO
measurement strategy in this population than calendar age
categories. Given the demonstrated saturation of concept in
the CE interviews and the positive feedback in the cogni-
tive interviews, there is good evidence that the chosen
methodology and sample sizes adequately support content
validity of the QPS in this population.
Ease of use and appropriate understanding of concept
are supported by the qualitative work and further supported
by the initial translation and linguistic validation process
that is currently under way to establish QPS translations for
other countries. The next step in the development of the
QPS is a psychometric validation study. This study and the
clinical studies to follow will cover an even greater
diversity in the target population including a large age
range of children with different reading levels as well as
different sensory, motor, and cognitive impairments. In
addition to performance characteristics such as reliability
and validity, the ability of the QPS to detect and quantify
improvements in SRP in clinical trials of botulinum toxin
treatment for spasticity in children with CP still needs to be
verified.
In summary, the QPS is the first PRO and ObsRO
instrument specifically developed for the assessment of
SRP in children and adolescents with CP. Importantly, the
QPS takes into account the special features of this patient
population, such as motor, cognitive, and communication
impairments that have not been addressed in other pediatric
PRO instruments. The QPS aims to allow clinicians and
researchers to reliably measure SRP in a way that is
meaningful to the children and adolescents with CP as well
as their parents or caregivers. This PRO and ObsRO has
been developed to monitor the effect of therapeutic inter-
ventions such as botulinum toxin injections on SRP to help
optimize treatment outcomes.
The QPS can be obtained by emailing the corresponding
author (scales@merz.de) at Merz Pharmaceuticals GmbH.
Acknowledgments We thank the following HRA team members:
Carla M. Ascoytia, Andrew J. Bryant, and Matthew J. Wolfe for help
with the interviews and data analysis. We also thank Francis Olson,
Rebecca Wynne, and Amanda Wydeveld from PROVAIL in Seattle
for their expert guidance around communicating with CP children.
894 Qual Life Res (2014) 23:887–896
123
Finally, we thank Connie Baker and the Wong-Baker FACESTM
Foundation for the permission to include the Wong-Baker FACES
scale in the QPS. Medical writing assistance was provided by Dr
Simone Boldt, Complete Medical Communications. This study was
sponsored by Merz Pharmaceuticals GmbH.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Aisen, M. L., Kerkovich, D., Mast, J., Mulroy, S., Wren, T. A.,
Kay, R. M., et al. (2011). Cerebral palsy: Clinical care and
neurological rehabilitation. Lancet Neurology, 10(9), 844–852.
doi:10.1016/S1474-4422(11)70176-4.
2. Center for Disease Control and Prevention. (2012). Facts about
cerebral palsy. http://www.cdc.gov/ncbddd/cp/facts.html. Acces-
sed October 3, 2012.
3. Dickinson, H. O., Parkinson, K. N., Ravens-Sieberer, U.,
Schirripa, G., Thyen, U., Arnaud, C., et al. (2007). Self-reported
quality of life of 8–12-year-old children with cerebral palsy: A
cross-sectional European study. Lancet, 369(9580), 2171–2178.
doi:10.1016/S0140-6736(07)61013-7.
4. Doralp, S., & Bartlett, D. J. (2010). The prevalence, distribution,
and effect of pain among adolescents with cerebral palsy. Pedi-
atric Physical Therapy, 22(1), 26–33. doi:10.1097/PEP.0b013e31
81ccbabb.
5. Lundy, C. T., Doherty, G. M., & Fairhurst, C. B. (2009). Botu-
linum toxin type A injections can be an effective treatment for
pain in children with hip spasms and cerebral palsy. Develop-
mental Medicine and Child Neurology, 51(9), 705–710. doi:10.
1111/j.1469-8749.2009.03315.x.
6. Massaro, M., Pastore, S., Ventura, A., & Barbi, E. (2013). Pain in
cognitively impaired children: A focus for general pediatricians.
European Journal of Pediatrics, 172(1), 9–14. doi:10.1007/
s00431-012-1720-x.
7. Parkinson, K. N., Gibson, L., Dickinson, H. O., & Colver, A. F.
(2010). Pain in children with cerebral palsy: A cross-sectional
multicentre European study. Acta Paediatrica, 99(3), 446–451.
doi:10.1111/j.1651-2227.2009.01626.x.
8. Chaleat-Valayer, E., Parratte, B., Colin, C., Denis, A., Oudin, S.,
Berard, C., et al. (2011). A French observational study of botu-
linum toxin use in the management of children with cerebral
palsy: BOTULOSCOPE. European Journal of Paediatric Neu-
rology, 15(5), 439–448. doi:10.1016/j.ejpn.2010.04.006.
9. Hadden, K. L., & von Baeyer, C. L. (2002). Pain in children with
cerebral palsy: Common triggers and expressive behaviors. Pain,
99(1–2), 281–288.
10. Ramstad, K., Jahnsen, R., Skjeldal, O. H., & Diseth, T. H. (2011).
Characteristics of recurrent musculoskeletal pain in children with
cerebral palsy aged 8 to 18 years. Developmental Medicine and
Child Neurology, 53(11), 1013–1018. doi:10.1111/j.1469-8749.
2011.04070.x.
11. Esquenazi, A., Mayer, N., Lee, S., Brashear, A., Elovic, E., Fran-
cisco, G. E., et al. (2012). Patient registry of outcomes in spasticity
care. American Journal of Physical Medicine and Rehabilitation,
91(9), 729–746. doi:10.1097/PHM.0b013e31824fa9ca.
12. Shaw, L. C., Price, C. I., van Wijck, F. M., Shackley, P., Steen,
N., Barnes, M. P., et al. (2011). Botulinum toxin for the upper
limb after stroke (BoTULS) trial: Effect on impairment, activity
limitation, and pain. Stroke, 42(5), 1371–1379. doi:10.1161/
STROKEAHA.110.582197.
13. Delgado, M. R., Hirtz, D., Aisen, M., Ashwal, S., Fehlings, D. L.,
McLaughlin, J., et al. (2010). Practice parameter: Pharmacologic
treatment of spasticity in children and adolescents with cerebral
palsy (an evidence-based review): Report of the Quality Standards
Subcommittee of the American Academy of Neurology and the
Practice Committee of the Child Neurology Society. Neurology,
74(4), 336–343. doi:10.1212/WNL.0b013e3181cbcd2f.
14. Love, S. C., Novak, I., Kentish, M., Desloovere, K., Heinen, F.,
Molenaers, G., et al. (2010). Botulinum toxin assessment, inter-
vention and after-care for lower limb spasticity in children with
cerebral palsy: International consensus statement. European
Journal of Neurology, 17(Suppl 2), 9–37. doi:10.1111/j.1468-
1331.2010.03126.x.
15. von Baeyer, C. L. (2006). Children’s self-reports of pain inten-
sity: Scale selection, limitations and interpretation. Pain
Research Management, 11(3), 157–162.
16. Cohen, L. L., Lemanek, K., Blount, R. L., Dahlquist, L. M., Lim,
C. S., Palermo, T. M., et al. (2008). Evidence-based assessment
of pediatric pain. Journal of Pediatric Psychology, 33(9),
939–955; discussion 956-937. doi:10.1093/jpepsy/jsm103.
17. Royal College of Nursing. (2009). The recognition and assessment
of acute pain in children. http://www.rcn.org.uk/_data/assets/pdf_
file/0004/269185/003542.pdf. Accessed November 27, 2012.
18. Hunt, A., Wisbeach, A., Seers, K., Goldman, A., Crichton, N.,
Perry, L., et al. (2007). Development of the paediatric pain pro-
file: Role of video analysis and saliva cortisol in validating a tool
to assess pain in children with severe neurological disability.
Journal of Pain and Symptom Management, 33(3), 276–289.
doi:10.1016/j.jpainsymman.2006.08.011.
19. Daltroy, L. H., Liang, M. H., Fossel, A. H., & Goldberg, M. J.
(1998). The POSNA pediatric musculoskeletal functional health
questionnaire: report on reliability, validity, and sensitivity to
change. Pediatric Outcomes Instrument Development Group.
Pediatric Orthopaedic Society of North America. Journal of
Pediatric Orthopedics, 18(5), 561–571.
20. Landgraf, J. A., Abetz, L., & Ware, J. (1996). The CHQ user’s
manual. Boston: The Health Institute, New England Medical
Center.
21. McCarthy, M. L., Silberstein, C. E., Atkins, E. A., Harryman, S.
E., Sponseller, P. D., & Hadley-Miller, N. A. (2002). Comparing
reliability and validity of pediatric instruments for measuring
health and well-being of children with spastic cerebral palsy.
Developmental Medicine and Child Neurology, 44(7), 468–476.
22. Varni, J. W., Seid, M., & Rode, C. A. (1999). The PedsQL:
Measurement model for the pediatric quality of life inventory.
Medical Care, 37(2), 126–139.
23. Collignon, P., & Giusiano, B. (2001). Validation of a pain eval-
uation scale for patients with severe cerebral palsy. European
Journal of Pain, 5(4), 433–442. doi:10.1053/eujp.2001.0265.
24. Boldingh, E. J., Jacobs-van der Bruggen, M. A., Lankhorst, G. J.,
& Bouter, L. M. (2004). Assessing pain in patients with severe
cerebral palsy: Development, reliability, and validity of a pain
assessment instrument for cerebral palsy. Archives of Physical
Medicine and Rehabilitation, 85(5), 758–766.
25. Patrick, D. L., Burke, L. B., Gwaltney, C. J., Leidy, N. K.,
Martin, M. L., Molsen, E., et al. (2011). Content validity—
establishing and reporting the evidence in newly developed
patient-reported outcomes (PRO) instruments for medical product
evaluation: ISPOR PRO Good Research Practices Task Force
report: Part 2—assessing respondent understanding. Value
Health, 14(8), 978–988. doi:10.1016/j.jval.2011.06.013.
26. Patrick, D. L., Burke, L. B., Gwaltney, C. J., Leidy, N. K.,
Martin, M. L., Molsen, E., et al. (2011). Content validity—
establishing and reporting the evidence in newly developed
Qual Life Res (2014) 23:887–896 895
123
patient-reported outcomes (PRO) instruments for medical product
evaluation: ISPOR PRO good research practices task force report:
Part 1—eliciting concepts for a new PRO instrument. Value
Health, 14(8), 967–977. doi:10.1016/j.jval.2011.06.014.
27. US Food and Drug Administration. (2009). Guidance for indus-
try—patient-reported outcome measures: Use in medical product
development to support labeling claims. http://www.fda.gov/
downloads/Drugs/GuidanceComplianceRegulatoryInformation/
Guidances/UCM193282.pdf. December 2009.
28. International Conference on Harmonisation. (1996). ICH harmo-




29. Baker, C. M., & Wong, D. L. (1987). Q.U.E.S.T.: A process of
pain assessment in children (continuing education credit).
Orthopaedic Nursing, 6(1), 11–21.
30. McGrath, P. J., Jhonson, G., Goodman, J. T., Schillinger, J., &
Dunn, J. (1985). The CHEOPS: A behavioral scale to measure
postoperative pain in children. In J. F. Chapman, R. Dubner, & F.
Cervero (Eds.), Advances in pain research and therapy (Vol. 9,
pp. 395–402). New York: Raven Press.
31. Merkel, S. I., Voepel-Lewis, T., Shayevitz, J. R., & Malviya, S.
(1997). The FLACC: A behavioral scale for scoring postoperative
pain in young children. Pediatric Nursing, 23(3), 293–297.
32. Beyer, J. E., Denyes, M. J., & Villarruel, A. M. (1992). The
creation, validation, and continuing development of the Oucher:
A measure of pain intensity in children. Journal of Pediatric
Nursing, 7(5), 335–346.
33. Tomlinson, D., von Baeyer, C. L., Stinson, J. N., & Sung, L.
(2010). A systematic review of faces scales for the self-report of
pain intensity in children. Pediatrics, 126(5), e1168–e1198.
doi:10.1542/peds.2010-1609.
34. Norquist, J. M., Girman, C., Fehnel, S., DeMuro-Mercon, C., &
Santanello, N. (2012). Choice of recall period for patient-reported
outcome (PRO) measures: Criteria for consideration. Quality of Life
Research, 21(6), 1013–1020. doi:10.1007/s11136-011-0003-8.
35. Rebok, G., Riley, A., Forrest, C., Starfield, B., Green, B., Rob-
ertson, J., et al. (2001). Elementary school-aged children’s reports
of their health: A cognitive interviewing study. Quality of Life
Research, 10(1), 59–70.
36. Chiou, C. F., Weaver, M. R., Bell, M. A., Lee, T. A., & Krieger, J.
W. (2005). Development of the multi-attribute Pediatric Asthma
Health Outcome Measure (PAHOM). International Journal for
Quality in Health Care, 17(1), 23–30. doi:10.1093/intqhc/mzh086.
37. Irwin, D. E., Varni, J. W., Yeatts, K., & DeWalt, D. A. (2009).
Cognitive interviewing methodology in the development of a
pediatric item bank: A patient reported outcomes measurement
information system (PROMIS) study. Health Qual Life Out-
comes, 7, 3. doi:10.1186/1477-7525-7-3.
896 Qual Life Res (2014) 23:887–896
123
